Arcutis Biotherapeutics (ARQT) traded down -3.11 % during a 24 hours period ending at 03:54 AM Central Europe on Tuesday 27th. One Arcutis Biotherapeutics stock can currently be bought for about USD 31.81 on popular exchanges. Current supply of Arcutis Biotherapeutics stocks is 125.6 mn. Arcutis Biotherapeutics has a current market capitalization of USD 3.9 bn and approximately USD 59.1 mn worth of Arcutis Biotherapeutics was traded on exchanges in the last 24 hours. Since last month end, Arcutis Biotherapeutics has traded 18.77 % up. Simple moving average of last 200 days is at USD 25.14. The highest price of past 52 weeks was recorded at USD 33.3 on 10/20/2026. 52 weeks low was at USD 19.3 on 05/19/2026.

Here is how related stocks have performed in the past 24 hours:

  • Ha Sustainable Infrastructur (HASI) traded down -0.6 % and now trades at USD 36.15. Current market capitalisation for Ha Sustainable Infrastructur is USD 4.7 bn. Ha Sustainable Infrastructur has a current price to earnings ratio of 54.83.

  • Vontier (VNT) traded down -0.52 % and now trades at USD 34.6. Vontier has a market capitalisation of USD 4.7 bn. Current price/earnings ratio for Vontier is 14.18.

  • Tfs (TFSL) traded down -0.36 % and now trades at USD 16.69. Current market capitalisation for Tfs is USD 4.7 bn. Current price/earnings ratio for Tfs is 46.22.

  • Mattel (MAT) traded down -3.13 % and now trades at USD 15.82. Mattel has a market capitalisation of USD 4.7 bn. Current price/earnings ratio for Mattel is 11.86.

  • Option Care Health (OPCH) traded down -0.22 % and now trades at USD 31.23. Option Care Health has a market capitalisation of USD 4.7 bn. Option Care Health has a current price to earnings ratio of 23.65.

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company that specializes in developing treatments for unmet needs in immune-mediated diseases and conditions. Based in Westlake Village, United States, this health care sector company strives to meet the medical sector’s requirements. You can learn more about their activities and offerings by visiting their website at www.arcutis.com . They are Nasdaq-listed.